|1.||Jańczyk, Agnieszka: 2 articles (07/2008 - 03/2008)|
|2.||Wolnicka-Głubisz, Agnieszka: 2 articles (07/2008 - 03/2008)|
|3.||Stochel, Grazyna: 2 articles (07/2008 - 03/2008)|
|4.||Macyk, Wojciech: 2 articles (07/2008 - 03/2008)|
|5.||Urbanska, Krystyna: 2 articles (07/2008 - 03/2008)|
|6.||Hey-Hawkins, Evamarie: 1 article (08/2015)|
|7.||Mijatović, Sanja: 1 article (08/2015)|
|8.||Kaluđerović, Milena R: 1 article (08/2015)|
|9.||Mojić, Marija: 1 article (08/2015)|
|10.||Kaluđerović, Goran N: 1 article (08/2015)|
08/05/2015 - "Importantly, [PtCl4(iBu2eddp)] did not induce necrosis in primary fibroblasts suggesting different intracellular response of normal vs. tumor cells. "
03/15/1994 - "These studies indicate that mitochondrial alterations may be an important component of CDDP resistance in these cell lines and that PtCl4(Rh-123)2 may represent a prototype platinum complex useful in the treatment of CDDP resistant tumors."
05/01/1990 - "Complexes of the tetrachloroplatinum(II) dianion PtCl4 with positively charged nuclear dyes have been designed in an effort to create new anticancer drugs for use with hyperthermia and/or radiation. "
11/15/1989 - "We are developing complexes of negatively charged PtCl4 with positively charged nuclear dyes as new antitumor agents for use alone and in conjunction with hyperthermia and/or radiation. "
07/01/1995 - "carboplatin/PtCl4(Nile Blue)2 (50 mg/kg), PtCl4(Rh-123)2/PtCl4(Fast Black)2 (100 mg/kg) under various combined schedules with hyperthermia treatment (43 degrees C, 30 min), similar cytotoxicity patterns were observed. "
01/01/1990 - "In an attempt to develop platinum-containing drugs for use with hyperthermia that would be relatively nontoxic at 37 degrees C but would become very cytotoxic at 42 degrees or 43 degrees C, several nuclear dyes were complexed to the tetrachloroplatinum(II) dianion (PtCl4) at a ratio of 2:1. The cytotoxicity of PtCl4 complexes of three thiazin dyes (thionin, azure B, and methylene blue), the xanthene dye pyronin Y, and the thiazole dye thioflavin was examined in exponentially growing euoxic and hypoxic EMT6 cells in vitro at 37 degrees, 42 degrees, and 43 degrees C and at pH 7.40 and 6.45. "
|3.||Phototoxic Dermatitis (Phototoxicity)
03/15/2008 - "In vitro experiments with the mouse melanoma cells (S-91) have demonstrated phototoxicity of the [TiO2/PtCl4] material. "
07/24/2008 - "Phototoxicity of titanium dioxide modified with platinum(IV)-chloride complexes, [TiO2/PtCl4], irradiated with visible light was tested on murine macrophage cell line (RAW 264.7) in vitro. "
03/15/2008 - "The visible light-induced phototoxicity of titanium dioxide modified with platinum(IV) chloride complexes, [TiO2/PtCl4], was tested. "
12/01/2000 - "800 consecutive subjects with contact dermatitis (n=749) and urticaria (n=51) were variously patch and prick tested with 30 haptens of a standard series, with aqueous solutions of, respectively, hexachloroplatinic acid (H2[PtCl6]), potassium tetrachloroplatinate (K2[PtCl4]), sodium hexachloroplatinate (Na2[PtCl6]), iridium chloride (IrCl3), rhodium chloride (RhCl3) and palladium chloride (PdCl2), and with 16 common inhalants. "
|2.||Coloring Agents (Dyes)
|3.||titanium dioxide (Titania)
|9.||Methylene Blue (Methylthioninium Chloride)